TP53 and breast cancer: In breast cancer cells, MDM2 overexpression or p53 KD reduced OVOL2 protein expression, and the proteasome inhibitor MG132 blocked the MDM2 overexpression‐ or p53 KD‐mediated reduction in OVOL2 expression (Figure 6B,C).